Company: HCWB
Filing Date: 2025-05-09
Form Type: S-1
Source: 0001193125-25-116745
Chunk: 96

Company: HCW Biologics Inc.
Filing Date: 2025-05-09
Form: S-1
Chunk 96
---
-K we filed with the SEC on April 1, 2025, as approved by our stockholders and board of directors on that date as
part of our plan to regain compliance with applicable continued listing rules of The Nasdaq Stock Market, we filed a Certificate of Amendment to our Certificate of Incorporation, as corrected, to effect a reverse stock split at a ratio of 40-to-1
with respect to shares of our Common Stock, which amendment became effective as of 12:01 a.m. Eastern time on April 11, 2025.

Our Transfer Agent

The transfer agent will continue to be Equiniti Trust Company, LLC.

Warrants

Common Stock Warrants

Overview. The following summary of certain terms and provisions of the Common Stock Warrants offered hereby is not complete and is
subject to, and qualified in its entirety by, the provisions of the warrant agency agreement between us and Equiniti Trust Company, LLC (the “Warrant Agent, and the form of Common Stock Warrant, each of which is filed as an exhibit to the
registration statement of which this prospectus is a part. Prospective investors should carefully review the terms and provisions set forth in the warrant agency agreement, including the annexes thereto and the form of Common Stock Warrant. Each
warrant issued in this offering entitles the registered holder to purchase one share of our Common Stock at a price equal to $[●] per share, subject to adjustment as discussed below, immediately following the issuance of such warrant and
terminating at 5:00 p.m., New York City time, on the fifth anniversary of the original issuance date.

Exercisability.The
Common Stock Warrants are exercisable at any time after their original issuance date until the fifth anniversary of the original issuance date. The Common Stock Warrants may be exercised upon surrender of the warrant on or prior to the expiration
date at the offices of the Warrant Agent, with the exercise form included with the Common Stock Warrant completed and executed as indicated. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to
the Common Stock issuable upon exercise of the Common Stock Warrants, the holders of the warrants shall have the right to exercise the warrants via a cashless exercise feature provided for in the Common Stock Warrants, until such time as there is an
effective registration statement and current prospectus. See “— Cashless Exercise” below.

Exercise Limitation. A holder (together with its affiliates